Newsroom

LONDON--(BUSINESS WIRE)--New research from Omdia shows that the semiconductor market delivered a record breaking performance in 3Q25 with industry revenue reaching $216.3bn, up 14.5% quarter-over-quarter (QoQ). This marks the first time the global semiconductor market has exceeded $200bn in a single quarter, following an already strong 2Q25, which saw 8% QoQ growth. At this pace, the industry is on track to exceed $800bn in total revenue for 2025. 3Q25 far exceeds seasonal expectations Demand f...

JEDDAH, Reino da Arábia Saudita--(BUSINESS WIRE)--A cidade de Jeddah testemunhou hoje um evento global histórico com o anúncio dos vencedores do Prêmio Global de Inovação em Água, em sua terceira edição, marcando a conclusão de uma competição acirrada que atraiu a atenção da comunidade internacional da área de recursos hídricos. Os vencedores foram revelados durante a cerimônia de abertura, realizada como parte da quarta edição da Conferência de Sustentabilidade Hídrica Impulsionada pela Inovaç...

RICHMOND, Va.--(BUSINESS WIRE)--Altria Group Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor...

HANOVER, Md.--(BUSINESS WIRE)--December 11, 2025 - Ciena® Corporation today announced financial results for its fiscal fourth quarter and year ended November 1, 2025....

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today reacted to the proxy statement supplement filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with respect to the proposed acquisition of the Company by Alcon Inc. (“Alcon”) (NYSE: ALC). In addition, Broadwood released a new presentation explaining why it continues to oppose the proposed transaction, which can be viewed here. Broadwood, which owns 3...

NUREMBERG, Germany--(BUSINESS WIRE)--VIA optronics Holding AG (OTC: VIAOY) (“VIA” or the “Company”), a leading supplier of interactive display solutions, today announced that members of its Management and Advisory team acquired the 50.32% stake from Coöperatief IMI Europe U.A.(“IMI”). Roland Chochoiek, Chief Executive Officer of VIA commented: “This management buyout strengthens our ability to execute our strategy, aligns leadership ownership with long-term performance, and positions the compan...

MANCHESTER, England--(BUSINESS WIRE)--Manchester United (NYSE: MANU; the “Company” and the “Group”) today announced financial results for the 2026 fiscal first quarter ended 30 September 2025. Management Commentary Omar Berrada, Chief Executive Officer, commented, “These robust financial results reflect the resilience of Manchester United as we make strong progress in our transformation of the club. The difficult decisions we have made in the past year have resulted in a sustainably lower cost...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourth quarter and full 2025 fiscal year results for the period ended September 30, 2025, along with a number of important recent achievements and highlights. Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon has made significant progress as a company to close out our fiscal year 2025...

MIAMI--(BUSINESS WIRE)--Consor Engineers (“Consor”), a leading North American engineering and advisory firm at the forefront of infrastructure modernization with differentiated capabilities across resiliency, reliability, sustainability, and security, today announced the appointment of Patrick Cassity as President and Chief Executive Officer (“CEO”) as part of a planned leadership succession. Cassity succeeds Dr. Hisham Mahmoud, who serves as Executive Chairman of the Board and as Interim CEO a...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially first-in-class therapeutics for common dermatologic conditions, today announced completion of enrollment in its Phase 2/3 registration-directed clinical trial evaluating VDPHL01, the potential first-ever extended-release oral minoxidil, for the treatment of male pattern hair loss. The company’s second Phase 3 male trial is actively enrolling...